PedAM
Pediatric Disease Annotations & Medicines
| Disease | ischemia |
| Phenotype | C0021171|incontinentia pigmenti |
| Sentences | 1 |
| PubMedID- 25313552 | Intravitreal bevacizumab as an adjunct therapy in incontinentia pigmenti with macular ischemia could be beneficial. |
Page: 1